Oncobiologics is a privately held biopharmaceutical company that began operations on October 14, 2011 with seed funding from a number of individual investors.  The company has since made excellent progress in achieving technical and business milestones, attracting investment from several respected institutional investors, including:

  • Cormorant Global healthcare Master Fund
  • Longwood Capital Partners
  • MIH Fund
  • OSSB Pharma Fund
  • Perceptive Advisors
  • Proximare Lifesciences Fund
  • Sabby Management
  • Strides Arcolab
  • VenBio Select Fund

In addition, Oncobiologics qualified for and received a federal government grant (QTDP) and also received government backed financing for equipment and facilities through the Small Business Administration (SBA).

For additional information, please contact